Oligomeric Aβ25–35 induces the tyrosine phosphorylation of PSD-95 by SrcPTKs in rat hippocampal CA1 subfield

References

• Knowles TP, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol. 2014;15(6):384–396.
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8(6):595–608.
   PubMed Web of Science ®Google Scholar
• Rajasekhar K, Chakrabarti M, Govindaraju T. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer’s disease. Chem Commun (Camb)). 2015;51(70):13434–13450.
   PubMed Web of Science ®Google Scholar
• Sengupta U, Nilson AN, Kayed R. The role of amyloid-β oligomers in toxicity, propagation, and immunotherapy. EBioMedicine. 2016;6:42–49.
   PubMed Web of Science ®Google Scholar
• Tu S, Okamoto S, Lipton SA, et al. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease. Mol Neurodegener. 2014;9:48.
   PubMed Web of Science ®Google Scholar
• Reiss AB, Arain HA, Stecker MM, et al. Amyloid toxicity in Alzheimer’s disease. Rev Neurosci. 2018;29(6):613–627.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192(1):106–113.
   PubMed Web of Science ®Google Scholar
• Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101–112.
   PubMed Web of Science ®Google Scholar
• Klementiev B, Novikova TV, Walmod P, et al. A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Aβ25–35. Neuroscience. 2007;145(1):209–224.
   PubMed Web of Science ®Google Scholar
• Zhou F, Xu Y, Hou XY. MLK3-MKK3/6-P38MAPK Cascades following NMDA receptor activation contributes to amyloid-peptide-induced apoptosis in SH-SY5Y cells. J Neurosci Res. 2014;92(6):808–817.
   PubMed Web of Science ®Google Scholar
• Xu Y, Cao DH, Wu GM, et al. Involvement of P38MAPK activation by NMDA receptors and non-NMDA receptors in amyloid-β peptide-induced neuronal loss in rat hippocampal CA1 and CA3 subfields. Neurosci Res. 2014;85:51–57.
   PubMed Web of Science ®Google Scholar
• Ball MJ. Neuronal loss, neurofibrillary tangles and grancelovascular degeneration in the hippocampus with aging and dementia. Acta Neuropathol. 1977;37(2):111–118.
   PubMed Web of Science ®Google Scholar
• Hrynchak MV, Rierola M, Golovyashkina N, et al. Chronic presence of oligomeric Aβ differentially modulates spine parameters in the hippocampus and cortex of mice with low APP transgene expression. Front Synaptic Neurosci. 2020;12:16.
   PubMed Web of Science ®Google Scholar
• Wu GM, Hou XY. Oligomerized Aβ25–35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield. Brain Res. 2010;1343:186–193.
   PubMed Web of Science ®Google Scholar
• Koppensteiner P, Trinchese F, Fà M, et al. Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer’s disease. Sci Rep. 2016;6:32553.
   PubMed Web of Science ®Google Scholar
• Sheng M, Hoogenraad CC. The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem. 2007;76:823–847.
   PubMed Web of Science ®Google Scholar
• Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci. 2004;5(10):771–781.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Salter MW. Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology. 2003;45(6):720–728.
   PubMed Web of Science ®Google Scholar
• Du CP, Gao J, Tai JM, et al. Increased tyrosine phosphorylation of PSD-95 by Src family kinases after brain ischaemia. Biochem J. 2009;417(1):277–285.
   PubMed Web of Science ®Google Scholar
• Zhao C, Du CP, Peng Y, et al. The upregulation of NR2A-containing N-methyl-D-aspartate receptor function by tyrosine phosphorylation of postsynaptic density 95 via facilitating Src/proline-rich tyrosine kinase 2 activation. Mol Neurobiol. 2015;51(2):500–511.
   PubMed Web of Science ®Google Scholar
• Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol. 2001;11(3):336–342.
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Murata Y, Okazawa H, et al. Src family kinases: modulators of neurotransmitter receptor function and behavior. Trends Neurosci. 2011;34(12):629–637.
   PubMed Web of Science ®Google Scholar
• Salter MW. Src, N-methyl-D-aspartate (NMDA) receptors, and synaptic plasticity. Biochem Pharmacol. 1998;56(7):789–798.
   PubMed Web of Science ®Google Scholar
• Lim SL, Tran DN, Zumkehr J, et al. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer’s disease-like neuropathology. Glia. 2018;66(12):2700–2718.
   PubMed Web of Science ®Google Scholar
• Yuan Xiang P, Janc O, Grochowska KM, et al. Dopamine agonists rescue Aβ-induced LTP impairment by Src-family tyrosine kinases. Neurobiol Aging. 2016;40:98–102.
   PubMed Web of Science ®Google Scholar
• Köhr G. NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 2006;326(2):439–446.
   PubMed Web of Science ®Google Scholar
• Iwamoto T, Yamada Y, Hori K, et al. Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins. J Neurochem. 2004;89(1):100–108.
   PubMed Web of Science ®Google Scholar
• Lin Y, Skeberdis VA, Francesconi A, et al. Postsynaptic density protein-95 regulates NMDA channel gating and surface expression. J Neurosci. 2004;24(45):10138–10148.
   PubMed Web of Science ®Google Scholar
• Roselli F, Tirard M, Lu J, et al. Soluble beta-amyloid1–40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci. 2005;25(48):11061–11070.
   PubMed Web of Science ®Google Scholar
• Li S, Hong S, Shepardson NE, et al. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron. 2009;62(6):788–801.
   PubMed Web of Science ®Google Scholar
• Niethammer M, Kim E, Sheng M. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95. J Neurosci. 1996;16(7):2157–2163.
   PubMed Web of Science ®Google Scholar
• Hynd MR, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity andneurodegeneration in Alzheimer’s disease. Neurochem Int. 2004;45(5):583–595.
   PubMed Web of Science ®Google Scholar
• Du CP, Tan R, Hou XY. Fyn kinases play a critical role in neuronal apoptosis induced by oxygen and glucose deprivation or amyloid-β peptide treatment. CNS Neurosci Ther. 2012;18(9):754–761.
   PubMed Web of Science ®Google Scholar
• Shao CY, Mirra SS, Sait HB, et al. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s disease. Acta Neuropathol. 2011;122(3):285–292.
   PubMed Web of Science ®Google Scholar
• Wong TP, Marchese G, Casu MA, et al. Loss of presynaptic and postsynaptic structures is accompanied by compensatory increase in action potential-dependent synaptic input to layer V neocortical pyramidal neurons in aged rats. J Neurosci. 2000;20(22):8596–8606.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Gingrich JR, Salter MW. Src in synaptic transmission and plasticity. Oncogene. 2004;23(48):8007–8016.
   PubMed Web of Science ®Google Scholar
• Zheng CY, Seabold GK, Horak M, et al. MAGUKs, synaptic development, and synaptic plasticity. Neuroscientist. 2011;17(5):493–512.
   PubMed Web of Science ®Google Scholar
• Bartos JA, Ulrich JD, Li H, et al. Postsynaptic clustering and activation of Pyk2 by PSD-95. J Neurosci. 2010;30(2):449–463.
   PubMed Web of Science ®Google Scholar
• Salazar SV, Cox TO, Lee S, et al. Alzheimer’s disease risk factor Pyk2 mediates amyloid-β-induced synaptic dysfunction and loss. J Neurosci. 2019;39(4):758–772.
   PubMed Web of Science ®Google Scholar
• Xu Y, Hou XY, Liu Y, et al. Different protection of K252a and N-acetyl-L-cysteine against amyloid-beta peptide-induced cortical neuron apoptosis involving inhibition of MLK3-MKK7-JNK3 signal Cascades. J Neurosci Res. 2009;87(4):918–927.
   PubMed Web of Science ®Google Scholar
• Savinainen A, Garcia EP, Dorow D, et al. Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling Cascades via post-synaptic density protein 95. J Biol Chem. 2001;276(14):11382–11386.
   PubMed Web of Science ®Google Scholar